Botanix Pharmaceuticals Limited
BXPHF
$0.02
$0.007.14%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -0.39% | -15.19% | -0.32% | 38.92% | -2.12% |
| Total Depreciation and Amortization | 0.39% | -0.39% | 0.31% | 5.75% | 2.11% |
| Total Amortization of Deferred Charges | 0.39% | -- | -- | -- | 2.11% |
| Total Other Non-Cash Items | 0.39% | 326.10% | 0.32% | -91.69% | 2.12% |
| Change in Net Operating Assets | -0.39% | -- | -- | -- | -2.12% |
| Cash from Operations | -0.39% | -18.56% | -0.32% | 35.62% | -2.12% |
| Capital Expenditure | 0.00% | 214.29% | 0.00% | 98.88% | -2.12% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.96% | 107.21% | -0.35% | -- | -- |
| Cash from Investing | 0.89% | 107.73% | -0.28% | -130.46% | -2.12% |
| Total Debt Issued | -- | -- | -- | -- | 0.00% |
| Total Debt Repaid | 0.00% | -1,267.09% | 0.00% | -57.25% | 0.00% |
| Issuance of Common Stock | 0.00% | 214,185.71% | 0.00% | -99.95% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -28.80% | 0.00% | 28.37% | 0.00% |
| Cash from Financing | 0.39% | 1,701.42% | -0.31% | -104.02% | 2.12% |
| Foreign Exchange rate Adjustments | 0.32% | 316.78% | -0.35% | 57.21% | -2.15% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.39% | 115.73% | -0.32% | -306.08% | 2.12% |